Latest News & Features
Americas
NPS Pharmaceuticals suffered a knock-back yesterday, when the US Court of Appeals for the Federal Circuit affirmed a decision which found that claims covering a patent owned by NPS were unpatentable. 16 November 2017
Americas
Bayer has entered into a global collaboration with biopharmaceutical company Loxo Oncology, in a deal that could be worth more than $1 billion. 16 November 2017
Americas
Janssen, a subsidiary of Johnson & Johnson, has dropped a lawsuit against Samsung's biopharmaceutical arm Samsung Bioepis. 15 November 2017
Americas
Excision BioTherapeutics has become the first company to secure exclusive licences from the University of California, Berkeley for “newly discovered” CRISPR gene editors. 15 November 2017
Big Pharma
Swiss-type second medical use patents can be infringed if a generic producer could have reasonably foreseen that its product would be used intentionally for the claimed use, according to the Supreme Court of the Netherlands. 14 November 2017
Americas
The US Court of Appeals for the Federal Circuit has reversed its findings in Life Technologies v Promega, nine months after the US Supreme Court limited overseas patent infringement. 14 November 2017
Americas
The National System for the Management of Genetic Heritage (SisGen) has been officially launched in Brazil. 14 November 2017
Americas
On November 7, the House Judiciary Committee’s subcommittee on IP took part in the “Sovereign Immunity and the Intellectual Property System” hearing. 13 November 2017
Americas
Thinking about how IP can assist a company long before it has fully developed is essential, says Leda Trivinos of Flagship Pioneering in an interview with LSIPR. 10 November 2017
Americas
Frazier Healthcare Partners has been responsible for creating and investing in multiple biotech companies, developing products from novel antibiotics to cancer therapies. James Topper, Frazier’s managing general partner, explains the firm’s philosophy. 10 November 2017